Odyssey Group International Inc
Odyssey Health, Inc., a medical company, focuses on the development and acquisition of medical products and health related technologies. The company develops CardioMap, a heart monitoring and screening device; and Save A Life choking rescue devices. Its product candidates include ONP-002 for the treatment of mild brain trauma or concussion. The company was formerly known as Odyssey Group Internat… Read more
Odyssey Group International Inc (ODYY) - Net Assets
Latest net assets as of October 2025: $-7.16 Million USD
Based on the latest financial reports, Odyssey Group International Inc (ODYY) has net assets worth $-7.16 Million USD as of October 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($143.62K) and total liabilities ($7.30 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-7.16 Million |
| % of Total Assets | -4981.96% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 3300.61 |
Odyssey Group International Inc - Net Assets Trend (2014–2025)
This chart illustrates how Odyssey Group International Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Odyssey Group International Inc (2014–2025)
The table below shows the annual net assets of Odyssey Group International Inc from 2014 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-07-31 | $-6.95 Million | -30.39% |
| 2024-07-31 | $-5.33 Million | +13.36% |
| 2023-07-31 | $-6.16 Million | -32.57% |
| 2022-07-31 | $-4.64 Million | -67.80% |
| 2021-07-31 | $-2.77 Million | -324.78% |
| 2020-07-31 | $-651.48K | -102.91% |
| 2019-07-31 | $22.39 Million | +2832.17% |
| 2018-07-31 | $-819.38K | -95.15% |
| 2017-07-31 | $-419.86K | -71.78% |
| 2016-07-31 | $-244.42K | -54.40% |
| 2015-07-31 | $-158.30K | -6704.13% |
| 2014-07-31 | $2.40K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Odyssey Group International Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 6260073400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (July 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $96.71K | % |
| Other Components | $55.69 Million | % |
| Total Equity | $-6.95 Million | 100.00% |
Odyssey Group International Inc Competitors by Market Cap
The table below lists competitors of Odyssey Group International Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Martina Minerals Corp
V:MTN-H
|
$799.02K |
|
Northern Shield Resources Inc
PINK:NSHRF
|
$799.43K |
|
ANGLO AM PLATINUM
MU:RPHA
|
$799.66K |
|
EBAY (EBA.SG)
STU:EBA
|
$799.83K |
|
China Nonferrous Gold Limited
PINK:CFEGF
|
$798.06K |
|
New Plus Knitting Public Company Limited
BK:NPK
|
$798.01K |
|
INCYTE - Dusseldorf Stock Exchang
DU:ICY
|
$798.00K |
|
I&M BANK RWANDA LTD
RSE:IMR
|
$797.89K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Odyssey Group International Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -5,333,749 to -6,954,698, a change of -1,620,949.
- Net loss of 1,742,691 reduced equity.
- Other factors increased equity by 121,742.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.74 Million | -25.06% |
| Other Changes | $121.74K | +1.75% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Odyssey Group International Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-07-31 | $0.00 | $0.01 | x |
| 2015-07-31 | $0.00 | $0.01 | x |
| 2016-07-31 | $0.00 | $0.01 | x |
| 2017-07-31 | $0.00 | $0.01 | x |
| 2018-07-31 | $-0.01 | $0.01 | x |
| 2019-07-31 | $0.32 | $0.01 | x |
| 2020-07-31 | $-0.01 | $0.01 | x |
| 2021-07-31 | $-0.03 | $0.01 | x |
| 2022-07-31 | $-0.05 | $0.01 | x |
| 2023-07-31 | $-0.07 | $0.01 | x |
| 2024-07-31 | $-0.05 | $0.01 | x |
| 2025-07-31 | $-0.07 | $0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Odyssey Group International Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-1513.57%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -18160.58% | 0.00% | 0.00x | 106.79x | $-435.55K |
| 2015 | 0.00% | -62.47% | 48.08x | 0.00x | $-144.87K |
| 2016 | 0.00% | -229.94% | 0.55x | 0.00x | $-61.68K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-155.86K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-401.18K |
| 2019 | -2.32% | 0.00% | 0.00x | 1.06x | $-2.76 Million |
| 2020 | 0.00% | -1822.56% | 2.52x | 0.00x | $-4.79 Million |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-17.68 Million |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-8.32 Million |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-5.30 Million |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-372.40K |
| 2025 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.05 Million |
Industry Comparison
This section compares Odyssey Group International Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Odyssey Group International Inc (ODYY) | $-7.16 Million | -18160.58% | N/A | $798.13K |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |